Hepion Pharmaceuticals Inc (HEPA)

$0.14 -0.18 (-57.55%)
Market Cap 4.28M
Revenue (ttm) 0.00
Net Income (ttm) -13.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,907,500
Avg Vol 5,820,207
Day's Range N/A - N/A
Shares Out 10.93M
Stochastic %K 55%
Beta 1.90
Analysts Strong Buy
Price Target $30.00

Company Profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It develops Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden;...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 902 4000
Address:
55 Madison Avenue, Suite 400 PMB No. 4362, Morristown, United States
prismmarketview
prismmarketview Mar. 17 at 4:28 PM
PRISM Mid-Day Movers: EV and AI Datacenter and Infrastructure are Today’s Leaders. AEye (NASDAQ: $LIDR) is up about 35–40% over two sessions after Q4 results showed ~$86.5M cash, no debt, and plans to cut 2026 cash burn as it shifts into commercial lidar programs. EdgeMode (OTC: $EDGM) is jumping roughly 30% as speculative money returns on its BAIF joint‑venture plan to build multi‑gigawatt AI data‑center capacity despite ongoing steep losses. Other Notable Movers: Numinus Wellness ( $NUMIF) up 28% Hepion Pharmaceuticals ( $HEPA) up 20% Comtech Communications ( $CMTL) down 27% https://prismmarketview.com/prism-mid-day-movers-ev-and-ai-datacenter-and-infrastructure-are-todays-leaders/
0 · Reply
prismmarketview
prismmarketview Mar. 10 at 4:43 PM
PRISM Mid-Day Movers: Global Health and Biotech are Today’s Leaders. Longeveron (NASDAQ: $LGVN ) is ripping ~71% as traders crowd into its stem‑cell story after Phase 2b data showed lead therapy laromestrocel improved 6‑minute walk distance by 63m in frail elderly patients and MRI biomarker work in Alzheimer’s pointed to reduced neuroinflammation, while new financing extends cash into late 2026. Polaryx Therapeutics (NASDAQ: $PLYX ) adds another ~22–23% to $3.52 as its thin float, fresh Nasdaq direct listing, Maxim $10 Buy rating, and plans for the SOTERIA Phase 2 basket trial of PLX‑200 across multiple lysosomal storage disorders keep momentum money pressing the bid. Other Notable Movers: LifeMD( $LFMD) up 20% Hepion Pharmaceuticals ( $HEPA) up 19% Allurion ( $ALUR) down -45% https://prismmarketview.com/prism-mid-day-movers-global-health-and-biotech-are-todays-leaders/
0 · Reply
StockNews_Live
StockNews_Live Mar. 3 at 12:35 PM
$HEPA Hepion Pharmaceuticals, Inc. announced the in-licensing of a novel biomarker assay from Cirna Diagnostics LLC to facilitate early diagnosis of hepatocellular carcinoma (HCC) in high-risk patients. The…
0 · Reply
Tacto
Tacto Feb. 28 at 12:55 AM
$HEPA 🙄
0 · Reply
MeatBallGuy
MeatBallGuy Feb. 25 at 3:20 AM
$HEPA hepa shit
0 · Reply
Pharm_Hand
Pharm_Hand Feb. 10 at 7:25 PM
$HEPA I motion for a full labiatic disclosure
1 · Reply
Pharm_Hand
Pharm_Hand Feb. 10 at 6:23 PM
$HEPA Someone unplug Labia's vibrator?
0 · Reply
Moneybucks
Moneybucks Jan. 31 at 12:29 AM
$HEPA
3 · Reply
Moneybucks
Moneybucks Jan. 30 at 4:38 PM
$HEPA Officers and Directors liability insurance ends Saturday
1 · Reply
Moneybucks
Moneybucks Jan. 27 at 4:56 PM
$HEPA https://www.ft.com/content/18ec669c-f832-4756-bc37-8cb33cb8899a
0 · Reply
Latest News on HEPA
No data available.
prismmarketview
prismmarketview Mar. 17 at 4:28 PM
PRISM Mid-Day Movers: EV and AI Datacenter and Infrastructure are Today’s Leaders. AEye (NASDAQ: $LIDR) is up about 35–40% over two sessions after Q4 results showed ~$86.5M cash, no debt, and plans to cut 2026 cash burn as it shifts into commercial lidar programs. EdgeMode (OTC: $EDGM) is jumping roughly 30% as speculative money returns on its BAIF joint‑venture plan to build multi‑gigawatt AI data‑center capacity despite ongoing steep losses. Other Notable Movers: Numinus Wellness ( $NUMIF) up 28% Hepion Pharmaceuticals ( $HEPA) up 20% Comtech Communications ( $CMTL) down 27% https://prismmarketview.com/prism-mid-day-movers-ev-and-ai-datacenter-and-infrastructure-are-todays-leaders/
0 · Reply
prismmarketview
prismmarketview Mar. 10 at 4:43 PM
PRISM Mid-Day Movers: Global Health and Biotech are Today’s Leaders. Longeveron (NASDAQ: $LGVN ) is ripping ~71% as traders crowd into its stem‑cell story after Phase 2b data showed lead therapy laromestrocel improved 6‑minute walk distance by 63m in frail elderly patients and MRI biomarker work in Alzheimer’s pointed to reduced neuroinflammation, while new financing extends cash into late 2026. Polaryx Therapeutics (NASDAQ: $PLYX ) adds another ~22–23% to $3.52 as its thin float, fresh Nasdaq direct listing, Maxim $10 Buy rating, and plans for the SOTERIA Phase 2 basket trial of PLX‑200 across multiple lysosomal storage disorders keep momentum money pressing the bid. Other Notable Movers: LifeMD( $LFMD) up 20% Hepion Pharmaceuticals ( $HEPA) up 19% Allurion ( $ALUR) down -45% https://prismmarketview.com/prism-mid-day-movers-global-health-and-biotech-are-todays-leaders/
0 · Reply
StockNews_Live
StockNews_Live Mar. 3 at 12:35 PM
$HEPA Hepion Pharmaceuticals, Inc. announced the in-licensing of a novel biomarker assay from Cirna Diagnostics LLC to facilitate early diagnosis of hepatocellular carcinoma (HCC) in high-risk patients. The…
0 · Reply
Tacto
Tacto Feb. 28 at 12:55 AM
$HEPA 🙄
0 · Reply
MeatBallGuy
MeatBallGuy Feb. 25 at 3:20 AM
$HEPA hepa shit
0 · Reply
Pharm_Hand
Pharm_Hand Feb. 10 at 7:25 PM
$HEPA I motion for a full labiatic disclosure
1 · Reply
Pharm_Hand
Pharm_Hand Feb. 10 at 6:23 PM
$HEPA Someone unplug Labia's vibrator?
0 · Reply
Moneybucks
Moneybucks Jan. 31 at 12:29 AM
$HEPA
3 · Reply
Moneybucks
Moneybucks Jan. 30 at 4:38 PM
$HEPA Officers and Directors liability insurance ends Saturday
1 · Reply
Moneybucks
Moneybucks Jan. 27 at 4:56 PM
$HEPA https://www.ft.com/content/18ec669c-f832-4756-bc37-8cb33cb8899a
0 · Reply
Moneybucks
Moneybucks Jan. 22 at 2:24 AM
$HEPA https://stocktwits.com/news-articles/markets/equity/nasdaq-exit-doesnt-shake-retail-bulls-as-hepion-preps-for-otc-trading/chi8chARbmZ
0 · Reply
Discernment
Discernment Jan. 16 at 5:38 PM
$HEPA More like "Dr." Lootbiati, pillaging the coffers of this company while getting zero work done. Is that MD degree even real, or just a third world fake one? Every time I hear her talk she reminds me of Kamala Harris, so can't imagine there's too much going on upstairs....
1 · Reply
BADBOYROY
BADBOYROY Jan. 15 at 10:07 PM
$HEPA Libiati is the new CEO effective Jan. 8th.
2 · Reply
Moneybucks
Moneybucks Jan. 15 at 1:51 AM
$HEPA Testing Testing One Two
1 · Reply
WindyCityDreamz
WindyCityDreamz Jan. 7 at 2:12 PM
$HEPA just checking in on the biggest fraud in the market!
1 · Reply
ARESTO
ARESTO Dec. 31 at 5:59 AM
$HEPA @Tacto @StupediaTrades Are you both here from 4 years ago. Can’t figure this out 🧐
0 · Reply
TradeWoFear
TradeWoFear Dec. 30 at 7:32 PM
$HEPA Congrats to all hold ... $APLT will follow soon imo...
0 · Reply
BADBOYROY
BADBOYROY Dec. 23 at 7:54 PM
$HEPA the new patent filings are not new per se. They are continuations of the patent applications previously filed years ago. It is interesting they waited until the company was essentially defunct to continue. It is also interesting that they decided to continue after the trials were halted. I don’t think they would spend all of that time and money if the data were poor. The Foster lawsuit was a ruse. If anyone can talk to Hobbs, he is the one who will tell the tale.
2 · Reply
Tacto
Tacto Dec. 17 at 11:37 AM
$HEPA @StupediaTrades Buy commodities, any f'n commodities. They are back at support, and they're all gonna be like gold! You can thank me later..
3 · Reply
Discernment
Discernment Dec. 13 at 5:35 PM
$HEPA I would have at least paid $5 for the rights to Rencofilstat. That's more tangible value than the zero dollars it was "sold" for and the CVRs that, by the company's own admission, were given no consideration and are likely worthless. Has anyone here ever seen a sales contract completed for zero dollars? Usually there is at least $1 to make it official.
1 · Reply
Moneybucks
Moneybucks Dec. 13 at 6:44 AM
$HEPA I will never sell what's the point at this point maybe if it went up some I would
2 · Reply